Our new understanding of heart failure: the role of beta-blockers in treatment.
Beta-blockers, long considered contraindicated in heart failure, improve left ventricular function in this disease by improving the biology of cardiac myocytes. Whether they improve survival remains to be determined.
Eichhorn
E J
EJ
Department of Internal Medicine (Cardiology Division), University of Texas Southwestern, Dallas, USA. eichhorn@ryburn.swmed.edu
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006333:Heart Failure / Q000175:diagnosis / Q000188:drug therapy* / Q000401:mortality; D006801:Humans; D011379:Prognosis; D015996:Survival Rate; D016896:Treatment Outcome
D000319:Adrenergic beta-Antagonists